This story has been updated with new information from a letter released today from Origin Technologies to Affymetrix demonstrating an increased financing committment and adressing other concerns.

NEW YORK (GenomeWeb) – An offer by former Affymetrix executives to buy the company under a newly formed shell corporation — and to pay off the cancellation penalties of Thermo Fisher Scientific's previously announced proposal to acquire Affy — has triggered a call and response between Affy, Thermo, and the newcomer Origin Technologies this week.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.